# A Study of LY3361237 in Healthy Participants

> **NCT03695198** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 64 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3361237 - SC
- **DRUG:** LY3361237 - IV
- **DRUG:** Placebo - SC
- **DRUG:** Placebo - IV

## Key facts

- **NCT ID:** NCT03695198
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-26
- **Primary completion:** 2019-08-29
- **Final completion:** 2019-08-29
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03695198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03695198, "A Study of LY3361237 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03695198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*